iiinova — where your digital self keeps evolving

Reposted by Jake Nysather DO

Nephgirlsketches @nephgirlsketch.bsky.social · 13/03/2025

Happy World Kidney Day!

1164

Reposted by Jake Nysather DO

Laura Ratcliffe @lauraratcliffe7.bsky.social · 28/02/2025

Happy #NephMadness Eve to all who celebrate!

Sidney the Kidney can barely contain his excitement at the thought of NephMadness 2025!

1117

Reposted by Jake Nysather DO

KDIGO @kdigo.org · 21/01/2025

1️⃣ We are pleased to announce the publication of the KDIGO 2025 ADPKD Guideline! This first-ever KDIGO guideline focused on a rare kidney disease provides practical tools to improve diagnosis, care, and treatment. Read the news release: kdigo.co/2025-ADPKD-G... #ADPKD

2239

Reposted by Jake Nysather DO

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 24/12/2024

1/n HydrANCAzine (hydralazine-induced ANCA-associated vasculitis has turn into an important cause of crescentic glomerulonephritis. Wonder how does hydralazine do it? Here is a tweetorial (BlueSkytorial?). I’ll start with an animation that summarizes and simplifies a proposed mechanism.

13215

Reposted by Jake Nysather DO

Sarah Sanghavi @sarahsanghavi.bsky.social · 16/12/2024

📟 Consulted a few times last week for, “Is this an RTA?” and my knee-jerk answer is “No”. 📖 The truth is that RTAs are rare though we talk about them a lot in med school. So here are some causes of a non-gap acidosis that are more common than an RTA. A 🧵 #nephsky #emimcc #icusky

23613

Reposted by Jake Nysather DO

Niralee Patel @nephralee.bsky.social · 07/12/2024

Celebrating the holidays together! Love our team ❤️ @drjakenysather.bsky.social @zacharysmithmd.bsky.social @jayminbpmd.bsky.social

Fellows, PD, and APD with the festive yet very cystic kidney

193

Reposted by Jake Nysather DO

Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 05/12/2024

Check out #KDIGOGems 💎 a dynamic new program offering virtual education on the latest @gokdigo.bsky.social Guidelines #Nephpearls Register here 👉 gems-gd.org/home

053

Reposted by Jake Nysather DO

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 05/12/2024

1/n happy to share a recent publication from Ochsner Nephrology at Kidney International Reports @kireports.bsky.social Nice visual abstract by Priti Meena. Link here: www.kireports.org/article/S246... But let me tell you the story a little bit…

23316

Reposted by Jake Nysather DO

Zachary Smith, M.D. @zacharysmithmd.bsky.social · 04/12/2024

Welcome new University of Cincinnati nephro fellows. A fun, rewarding, always interesting experience awaits. Excited to meet everyone. @gudnephron.bsky.social @drjakenysather.bsky.social

272

Reposted by Jake Nysather DO

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 25/11/2024

New today - @thelancet.bsky.social DM/Endo GLP1RAs and kidney/CV outcomes - SR from @sunilbadve.bsky.social Tuttle, Perkovic et al www.thelancet.com/journals/lan... ($🔒) - with/out DM - kidney outcomes (not albuminuria)

Forest plot of kidney outcomes with GLP1RAs

1379

Reposted by Jake Nysather DO

Nephrology Journal Club @nephjc.bsky.social · 20/11/2024

👉Before we start, a few reminders! Are you new to #NephJC? Not sure what to do or how this works? Here is a quick rundown. 💡Remember: the simplest rule is to be kind and inclusive while you use your wit! ⏰ We’ll get started in 15min!

1153

Reposted by Jake Nysather DO

Kenar Jhaveri, MD @kdjhaveri.bsky.social · 19/11/2024

www.era-online.org/publications...

era-online.org

C3 Glomerulopathy | ERA

032

Jake Nysather DO @drjakenysather.bsky.social · 15/11/2024

Had a great time with everyone @NKFCincy #DriveForDialysis. Look forward to surprising some patients with some goodies! @govil_amit @UCKidney #NKF

091

Reposted by Jake Nysather DO

Prakash Gudsoorkar @gudnephron.bsky.social · 12/11/2024

Join for the Onconeph education series #onconeph

072

Reposted by Jake Nysather DO

Rob Blaser @robertblaser.bsky.social · 12/11/2024

So folks, one of my primary responsibilities for RPA is to monitor the U.S. Medicare Fee Schedule for nephrology; this will be a thread with key highlights from the 2025 fee schedule which came out November 1. To be transparent, much of this was sent to RPA members yesterday.

1144

Reposted by Jake Nysather DO

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 12/11/2024

The most effective pharmacological and hemodynamic intervention for the treatment of hepatorenal syndrome #HRS is a substantial MAP raise, as illustrated in this case example

13514